The Journal of Clinical Psychiatry

Page 290

More JCP Articles

Letter to the Editor

Risks of Intermittent Antipsychotic Treatment in Schizophrenia

January 15, 2011

Koichiro Watanabe, Takefumi Suzuki, Kensuke Nomura

Letter to the Editor

Schizophrenia-Related Outpatient Treatment of Medicaid-Financed Patients After Hospital Discharge

January 15, 2011

Maurits van den Noort, Peggy Bosch

Editorial

Our Sincere Thanks

January 15, 2011

Marlene P. Freeman, Alan J. Gelenberg

Original Research

Suicidality in Obsessive-Compulsive Disorder: Prevalence and Relation to Symptom Dimensions and Comorbid Conditions

January 15, 2011

Leonardo F. Fontenelle, Euripedes C. Miguel, Ygor A. Ferrão, et al

Book Review

Windows to the Brain: Insights From Neuroimaging

January 15, 2011

Howard S. Kirshner

Educational Activity

Pharmacotherapy for Late-Life Depression

January 15, 2011

George S. Alexopoulos

Educational Activity

Strategies for Selecting Treatment and Mitigating Risk in Patients With Chronic Pain

January 15, 2011

Scott M. Fishman

Educational Activity

Addressing Adverse Effects of Antipsychotic Treatment in Young Patients With Schizophrenia

January 15, 2011

Christoph U. Correll

Educational Activity

Alternatives to Antidepressants in Treating Acute Bipolar Depression

January 15, 2011

Andrew A. Nierenberg

Original Research

The Association Between Social Isolation and DSM-IV Mood, Anxiety, and Substance Use Disorders: Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions

January 11, 2011

Jitender Sareen, Kee-Lee Chou, Kun Liang

Original Research

The "Doses" of Initial, Untreated Hallucinations and Delusions: A Proof-of-Concept Study of Enhanced Predictors of First-Episode Symptomatology and Functioning Relative to Duration of Untreated Psychosis

January 11, 2011

Michael T. Compton, Elaine F. Walker, Tynessa L. Gordon, et al

Original Research

Effectiveness and Safety of Vagus Nerve Stimulation for Severe Treatment-Resistant Major Depression in Clinical Practice After FDA Approval: Outcomes at 1 Year

January 11, 2011

Michael E. Thase, Pilar Cristancho, Mario A. Cristancho, et al

« 1 … 288 289 290 291 292 … 770 »

Risks of Intermittent Antipsychotic Treatment in Schizophrenia

Schizophrenia-Related Outpatient Treatment of Medicaid-Financed Patients After Hospital Discharge

Our Sincere Thanks

Suicidality in Obsessive-Compulsive Disorder: Prevalence and Relation to Symptom Dimensions and Comorbid Conditions

Windows to the Brain: Insights From Neuroimaging

Pharmacotherapy for Late-Life Depression

Strategies for Selecting Treatment and Mitigating Risk in Patients With Chronic Pain

Addressing Adverse Effects of Antipsychotic Treatment in Young Patients With Schizophrenia

Alternatives to Antidepressants in Treating Acute Bipolar Depression

The Association Between Social Isolation and DSM-IV Mood, Anxiety, and Substance Use Disorders: Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions

The "Doses" of Initial, Untreated Hallucinations and Delusions: A Proof-of-Concept Study of Enhanced Predictors of First-Episode Symptomatology and Functioning Relative to Duration of Untreated Psychosis

Effectiveness and Safety of Vagus Nerve Stimulation for Severe Treatment-Resistant Major Depression in Clinical Practice After FDA Approval: Outcomes at 1 Year

ELSEWHERE:

FOLLOW US:

More JCP Articles

Risks of Intermittent Antipsychotic Treatment in Schizophrenia

Schizophrenia-Related Outpatient Treatment of Medicaid-Financed Patients After Hospital Discharge

Our Sincere Thanks

Suicidality in Obsessive-Compulsive Disorder: Prevalence and Relation to Symptom Dimensions and Comorbid Conditions

Windows to the Brain: Insights From Neuroimaging

Pharmacotherapy for Late-Life Depression

Strategies for Selecting Treatment and Mitigating Risk in Patients With Chronic Pain

Addressing Adverse Effects of Antipsychotic Treatment in Young Patients With Schizophrenia

Alternatives to Antidepressants in Treating Acute Bipolar Depression

The Association Between Social Isolation and DSM-IV Mood, Anxiety, and Substance Use Disorders: Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions

The "Doses" of Initial, Untreated Hallucinations and Delusions: A Proof-of-Concept Study of Enhanced Predictors of First-Episode Symptomatology and Functioning Relative to Duration of Untreated Psychosis

Effectiveness and Safety of Vagus Nerve Stimulation for Severe Treatment-Resistant Major Depression in Clinical Practice After FDA Approval: Outcomes at 1 Year

Consensus Report on XT Use in Practice

Subscribe to readmore articles

Subscribe to read
more articles